Lung Neoplasms: all 7,334 studies

Page 13 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.

• Comparision of Various Biomarkers Between Peripheral and Pulmonary BloodRecruitingNCT05587114
• Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision RadiotherapyRecruitingNCT05584267Phase 2
• SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLCNot yet recruitingNCT05583409Not applicable
• Study of Trilaciclib and LurbinectidinRecruitingNCT05578326Phase 2
• Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung CancerRecruitingNCT05573373Phase 1
• Formatting the Risk Prediction Models for Never-Smoking Lung CancerRecruitingNCT05572944
• SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung CancerRecruitingNCT05570825Phase 2
• Prognostic Value of Lung Cancer MicroAnatomy in 3DNot yet recruitingNCT05565677
• Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung CancerRecruitingNCT05557552Not applicable
• Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion AdministrationRecruitingNCT05557487
• Development and Clinical Validation of Early-stage Lung Cancer Prognostic KitRecruitingNCT05557474
• APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational ReaserchRecruitingNCT05550961
• First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon MutationRecruitingNCT05548348Phase 2
• 68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer PatientsRecruitingNCT05543954Early Phase 1
• PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN StudyRecruitingNCT05542485
• The Use of Molecular Radiogenomics in Non-small Cell Lung CancerRecruitingNCT05541744
• I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With ImmunotherapyRecruitingNCT05537922
• Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLCNot yet recruitingNCT05534113Phase 2
• Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC PatientsRecruitingNCT05532696Phase 1/2
• Erector Spinae Block for Thoracic SurgeryRecruitingNCT05521789Phase 4
• Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary MetastasesRecruitingNCT05518526Phase 1/2
• Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C MutationRecruitingNCT05504278Phase 1
• Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung CancerNot yet recruitingNCT05503888Phase 1/2
• Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung CancerRecruitingNCT05502913Phase 2
• The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung CancerRecruitingNCT05502523Not applicable
• Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerRecruitingNCT05501665Phase 1/2
• EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerNot yet recruitingNCT05498389Phase 1/2
• Psychosocial eHealth in Advanced Lung CancerRecruitingNCT05497973Not applicable
• ORE - 30 Seconds (Oncologists Recommend Exercise in 30 Secs)RecruitingNCT05497544Not applicable
• The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung CancerNot yet recruitingNCT05496166Phase 3
• China Lung Cancer Screening (CLUS) Study Version 3.0RecruitingNCT05494021Not applicable
• Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung CancerRecruitingNCT05493566Early Phase 1
• VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung CancerRecruitingNCT05489731Phase 1
• ctDNA as a Biomarker for Treatment in Advanced NSCLCNot yet recruitingNCT05486988
• Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With OligometastasesNot yet recruitingNCT05484583Phase 2
• KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung CancerRecruitingNCT05483491Phase 1
• The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)RecruitingNCT05477979
• Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation TherapyRecruitingNCT05468242Phase 2
• EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung CancerRecruitingNCT05467748Phase 1/2
• InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruitingNCT05463796
• Empathic Communication Skills (ECS) TrainingRecruitingNCT05456841Not applicable
• A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung AdenocarcinomaRecruitingNCT05456256Phase 2
• Lung Cancer Screening Implementation Among Employees at Lyon HospitalRecruitingNCT05452200Not applicable
• Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung CancerRecruitingNCT05452005Phase 1
• Combining ICI With SBRT or HypoFrx-RT for ES NSCLCNot yet recruitingNCT05451173Phase 1/2
• An Open-label, Phase 2trial of Sotorasib in KRAS G12C-mutant Non-small-cell Lung Cancer(NSCLC) Patients and a Translational Study to Find Acquired Resistance Mechanism to SotorasibNot yet recruitingNCT05451056Phase 2
• Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung CancerRecruitingNCT05450965Phase 2
• Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung CancerRecruitingNCT05445310Phase 2
• Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC PatientsRecruitingNCT05443646Phase 2
• Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung CancerRecruitingNCT05435274Phase 1/2
• Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaRecruitingNCT05433142Phase 1
• Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis StudyRecruitingNCT05432739
• Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung CancerRecruitingNCT05430009Phase 1
• A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the BrainRecruitingNCT05419076Phase 2
• Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung CancerRecruitingNCT05416775Phase 1/2
• A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung CancerNot yet recruitingNCT05414630Phase 2
• Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
• Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung CancerRecruitingNCT05401110Phase 1
• Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapyRecruitingNCT05398094Phase 2
• A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLCRecruitingNCT05394831Phase 1/2
• PD1 and PARP for Maintenance Therapy in NSLLCRecruitingNCT05392686Phase 2
• DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction SolutionRecruitingNCT05389774
• Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung CancerRecruitingNCT05384873Not applicable
• The Red Blood Cells Based Blood Test for Lung Cancer EARLY DetectionNot yet recruitingNCT05380999
• Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRecruitingNCT05379985Phase 1/2
• The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?RecruitingNCT05378633Not applicable
• AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung CancerRecruitingNCT05377658Phase 2
• cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881
• A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerRecruitingNCT05361174Phase 1/2
• A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLCEnrolling by invitationNCT05360979Phase 2
• A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal MetastasisNot yet recruitingNCT05359393Phase 2
• ATATcH Alternating Treatment Plans for Advanced CancerRecruitingNCT05358548Phase 2
• Multiomics Tumor Evolution Model of NSCLCRecruitingNCT05352035
• WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLCRecruitingNCT05351320Phase 2
• Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung CancerRecruitingNCT05341583Phase 3
• EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast CancerRecruitingNCT05341492Early Phase 1
• Patient's Whole Process Follow-up Management(HOPE-1)RecruitingNCT05339568
• A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation TherapyRecruitingNCT05338619Phase 2
• Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNARecruitingNCT05334277Phase 2
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
• Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer PatientsRecruitingNCT05319886
• Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With ComorbiditiesRecruitingNCT05311709Phase 2
• Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary NodulesRecruitingNCT05306912Not applicable
• Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung CancerNot yet recruitingNCT05306847Phase 2
• Exercise in Extended Oncogene Addicted Lung Cancer in Active TreatmentRecruitingNCT05306652Not applicable
• Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
• Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung CancerRecruitingNCT05296603Phase 2
• Efficacy and Biomarker Explanation of IBI-323 + Bevacizumab Plus Platinum Based Chemotherapy on ALK-Rearranged NSCLCRecruitingNCT05296278Phase 2
• Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIBRecruitingNCT05295212Phase 2
• Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung CancerRecruitingNCT05292521Not applicable
• Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung CancerRecruitingNCT05284539Phase 2
• Avecure Flexible Microwave Ablation Probe For Lung NodulesRecruitingNCT05281237Not applicable
• First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R MutationsRecruitingNCT05271916Phase 1/2
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsRecruitingNCT05269381Phase 1/2
• Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)RecruitingNCT05267041Not applicable
• COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)RecruitingNCT05258448
• Personalized Estimation of Doses Delivered During Image Guided Radiation Therapy TestsNot yet recruitingNCT05258383
• Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via ImagingNot yet recruitingNCT05254132
• Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung CancerRecruitingNCT05244239Phase 1
• A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung CancerRecruitingNCT05242965Phase 2Results posted

← Lung Neoplasms overview